单位:[1]Beijing Chao-Yang Hospital, Beijing Institute of Respiratory Medicine, Capital Medical University, Beijing, China北京朝阳医院[2]Respiratory and Critical Care Medicine 2#, China-Japan Friendship Hospital, Beijing, China[3]Department of Infectious diseases and Clinical Microbiology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China北京朝阳医院
IntroductionBinax NOW rapid immunochromatographic membrane test (ICT), a rapid method for detection of Streptococcus pneumoniae antigen, has been used widely in Europe and America, but rarely in China. ObjectiveOur aim is to evaluate the utility of the ICT among adult patients with community acquired pneumonia (CAP) in China. MethodsAdult patients with CAP were prospectively recruited from 12 general hospitals. ICT tests were done in all patients and clinical data were recorded. Qualified sputum culture was used as the standard for determining the diagnostic usefulness of ICT test. ResultThousand hundred fifty four CAP patients were enrolled in analysis, with median (IQR) age of 48 (35) years. 276 (23.9%) patients had underling diseases, 770 (66.7%) had received antibiotics before ICT test. Overall, the positive rate of ICT test was 3.3%, with sensitivity and specificity 57.9% and 96.6%, respectively. Disease severity, chronic obstructive pulmonary disease (COPD), increased age; respiratory rate (RR), neutrophil ratio, blood urea nitrogen (BUN), procalcitonin (PCT) and the decreased oxygenation index were associated with positive results of ICT tests. Patients with BUN >7 mmol/L, CURB-65 3-5, PCT>2ng/mL were the top three groups with highest positive rate of ICT test (22.6%, 22.2% and 21.1% respectively). ConclusionICT test has a moderate sensitivity and high specificity in adults with CAP in China. Patients classified as sever pneumonia, or those with BUN>7 mmol/L, or PCT>2 ng/mL are more likely to have positive results.
基金:
National Science Fund for Distinguished Young ScholarsNational Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars [81425001/H0104]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271840/H1904, 81030032/H19]; Beijing Municipal Commission of Science and Technology [D101100049810002, D151100002115004]
第一作者单位:[1]Beijing Chao-Yang Hospital, Beijing Institute of Respiratory Medicine, Capital Medical University, Beijing, China[2]Respiratory and Critical Care Medicine 2#, China-Japan Friendship Hospital, Beijing, China
通讯作者:
通讯机构:[1]Beijing Chao-Yang Hospital, Beijing Institute of Respiratory Medicine, Capital Medical University, Beijing, China[2]Respiratory and Critical Care Medicine 2#, China-Japan Friendship Hospital, Beijing, China[*1]Beijing Chao-Yang Hospital, Beijing Institute of Respiratory Medicine, Capital Medical University, 8 Gongti Road, Chaoyang District, Beijing 10020, China. China-Japan Friendship Hospital, Beijing, No 2 Ying hua yuan Dongjie, Chao Yang District, Beijing 100029, China
推荐引用方式(GB/T 7714):
Zhou Fei,Gu Li,Qu Jiu Xin,et al.Evaluating the utility of Binax NOW Streptococcus pneumoniae urinary antigen test in adults with community acquired pneumonia in China[J].CLINICAL RESPIRATORY JOURNAL.2018,12(2):425-432.doi:10.1111/crj.12533.
APA:
Zhou, Fei,Gu, Li,Qu, Jiu Xin,Liu, Ying Mei&Cao, Bin.(2018).Evaluating the utility of Binax NOW Streptococcus pneumoniae urinary antigen test in adults with community acquired pneumonia in China.CLINICAL RESPIRATORY JOURNAL,12,(2)
MLA:
Zhou, Fei,et al."Evaluating the utility of Binax NOW Streptococcus pneumoniae urinary antigen test in adults with community acquired pneumonia in China".CLINICAL RESPIRATORY JOURNAL 12..2(2018):425-432